[Osteoporosis: its diagnosis, its consequences].
Osteoporosis is a metabolic bone disease characterized by an increased risk of fractures, especially hip, wrist and vertebral fractures. Osteoporosis occurs more commonly in women because of a bone loss after menopause. Post menopausal bone loss is prevented by estrogen replacement therapy. An adequate calcium intake remains important. Sodium fluoride and biphosphonates are the main other treatments of osteoporosis.
Hardouin
P
P
Institut de Recherche sur les Maladies du Squelette, Institut Calot, Berck sur Mer.
D015502:Absorptiometry, Photon; D000293:Adolescent; D000328:Adult; D000368:Aged; D001862:Bone Resorption / Q000209:etiology; D002136:Calcium, Dietary / Q000008:administration & dosage / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D004958:Estradiol / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy; D005260:Female; D050723:Fractures, Bone / Q000209:etiology; D006620:Hip Fractures / Q000209:etiology; D006801:Humans; D007571:Jaw Diseases / Q000209:etiology; D010024:Osteoporosis / Q000150:complications / Q000175:diagnosis* / Q000517:prevention & control; D015663:Osteoporosis, Postmenopausal / Q000150:complications / Q000175:diagnosis / Q000517:prevention & control; D012307:Risk Factors; D012737:Sex Factors; D012969:Sodium Fluoride / Q000627:therapeutic use; D016103:Spinal Fractures / Q000209:etiology; D014954:Wrist Injuries / Q000209:etiology
D002136:Calcium, Dietary; D004164:Diphosphonates; D004958:Estradiol; D012969:Sodium Fluoride
L'ostéoporose: son diagnostic, ses conséquences.